| dc.description.abstract | Background: Upper gastrointestinal bleeding is a very prevalent condition and its prevalence
in Uganda is about 20.3%. Many studies have not yet identified prevalence, treatment outcome
and factors associated with upper gastrointestinal bleeding in Amolatar and these necessitated
this study.
Objective: This aimed at determining the prevalence, treatment outcome, and factors
associated with upper gastrointestinal bleeding among adult patients in Amolatar District,
Northern Uganda.
Methods: A cross-sectional study design was performed between January 2021 and December
2022 in five selected health facilities. Data was collected using a data extraction form on socio-
demographic characteristics, health related factors and treatment outcomes. Data was entered
and analyzed using SPSS version 20 at the level of univariate, bi-variate and multivariate to
identify variables that were significantly associated with UGIB.
Results: According to the study, the prevalence of upper gastrointestinal bleeding in Amolatar
was found to be 24.5%. with all patients who were treated for UGIB (73.8%) treated and
improved, (24.6%) were referred and (1.6%) patient died. Alcohol consumption (AOR: 2.261;
CI 95%, 1089-4.634; p=0.026) and previous history of UGIB (AOR: 13.01; CI 95%, 6.723-
25.512; p=0.001) are factors found to be associated with UGIB.
Conclusion: The prevalence of Upper gastrointestinal bleeding was at 24.5%, with all patients
treated for UGIB, (73.8%) treated and improved, 24.6% were referred and the mortality rate
stood at 1.6%. previous history of UGIB and alcohol consumption were independently
significantly associated with Upper gastrointestinal bleeding.
Recommendations: Further study on outcomes and factors associated with Upper
gastrointestinal bleedings. Provision of health educations and sensitizations to the community
on the causes, risks factors and the health outcomes of Upper gastrointestinal bleedings need
to be undertaken.
Keywords: Prevalence, Treatment Outcomes, Upper-Gastrointestinal Bleeding, Adult In-
Patients | en_US |
